Western Australia Atropine for the Treatment of Myopia (WA-ATOM) study: Rationale, methodology and participant baseline characteristics.

Samantha Sze-Yee Lee David A Mackey Gareth Lingham Julie M CreweMichael D RichardsFred K ChenJason CharngFletcher NgIan FlitcroftJames J LoughmanAugusto Azuara-BlancoNicola S LoganChristopher J HammondAudrey ChiaTan Tai TruongAntony Clark

Published in: Clinical & experimental ophthalmology (2020)

Outcomes of the WA-ATOM study will inform on the efficacy, tolerability, safety and long-term effects of low-dose atropine eyedrops in myopia control in Australian children. The impact of ocular sun exposure, iris colour and parental myopia on the efficacy of low-dose atropine will also be assessed.

Keyphrases

low dose
high dose
molecular dynamics

young adults
randomized controlled trial

clinical trial
south africa

type diabetes
metabolic syndrome